Q3 2017 13F Holders as of 9/30/2017
-
Type / Class
-
Equity / Common Stock, par value $0.01 per share
-
Shares outstanding
-
309M
-
Number of holders
-
180
-
Total 13F shares, excl. options
-
198M
-
Shares change
-
+24.3M
-
Total reported value, excl. options
-
$2.99B
-
Value change
-
+$374M
-
Put/Call ratio
-
1.12
-
Number of buys
-
124
-
Number of sells
-
-50
-
Price
-
$15.08
Significant Holders of AMICUS THERAPEUTICS, INC. - Common Stock, par value $0.01 per share (FOLD) as of Q3 2017
236 filings reported holding FOLD - AMICUS THERAPEUTICS, INC. - Common Stock, par value $0.01 per share as of Q3 2017.
AMICUS THERAPEUTICS, INC. - Common Stock, par value $0.01 per share (FOLD) has 180 institutional shareholders that have filed 13F forms with the Securities Exchange Commission (SEC).
These institutions hold a total of 198M shares
of 309M outstanding shares and own 64.23% of the company stock.
Largest 10 shareholders include FMR LLC (19.3M shares), PERCEPTIVE ADVISORS LLC (17.9M shares), BlackRock Inc. (13.4M shares), VANGUARD GROUP INC (13.3M shares), Redmile Group, LLC (11M shares), JENNISON ASSOCIATES LLC (9.77M shares), STATE STREET CORP (8.15M shares), PRICE T ROWE ASSOCIATES INC /MD/ (8.09M shares), JANUS HENDERSON GROUP PLC (7.43M shares), and Palo Alto Investors, LLC (7.42M shares).
This table shows the top 180 institutional shareholders of the company equity. This data is sourced directly from the SEC via 13F filings.
| Investor |
Option |
Weight % |
Change % |
Value $ |
* Price $ |
Shares |
Share Change |
Activity |
Report Period |
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.